Leadership team expanded with addition of Chief Corporate Development Officer, Ted Hibben, a 25-year venture-stage business development biotherapeutic industry veteran
Total venture funding tops $50M to date

Sapio's No-Code ELN to Provide Enhanced Collaboration, Unified Data Access, and Flexible Workflows to viral vector CDMO Oxford Biomedica

AmplifyBio is adding manufacturing services, starting with cell therapy and plasmids, to its growing capabilities to support the safe development of advanced therapies.

CGT cGMP Production Facilities in US and China

AmplifyBio builds on the T-cell immunology expertise of its South San Francisco-based team, adding technology platforms and capabilities in single-cell analysis and product assessment in the context of a tumor microenvironment.

Forecyte Bio, CGT CDMO leader, officially opened its cGMP production suites for plasmid DNA, viral vector and cell therapy productions.

The Global Community of Hematopoietic Cell Transplantation and Cellular Therapy Specialists will Gather for the 2023 Tandem Meetings to Improve the Lives of Patients with Blood-Related Disorders and Solid Tumors.

Experienced operational executive to lead OcyonBio through its next stage of growth

Experienced finance and operational executive to lead OcyonBio through its next stage of growth

OcyonBio CDMO welcomes cell and gene therapy expert Robert Salcedo who brings over 20 years of expertise in the areas of CMC, operations, and supply chain management and has served in multi-billion-dollar companies operating in biotech, vaccines, and pharmaceutical markets.

New 25,000-square-foot state-of-the-art cGMP manufacturing facility in West Sacramento, CA, quadruples manufacturing capacity as the company continues to remain focused on serving the cell and gene therapy market

Every year, The Medicine Maker, a leading, global publication in cell and gene therapy, lists the world's top 100 thought leaders and opinion shapers who have carried out life-changing work in the biopharmaceutical industry, helping thousands of people across the globe.

World Stem Cell Summit and Phacilitate Leaders World to bring FOUR Meetings Together to Create Collaboration Needed to Deliver Global Cell and Gene Therapies!

ISCT confirmed as strategic partner for Phacilitate's trade mission to Asia, June 2018

This pipeline analysis focuses on Immune Checkpoint therapeutics.